Open AccessThe effects of antihypertensive class on gout in older adults: secondary analysis of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial
Author(s) -
Stephen P. Juraschek,
Lara M. Simpson,
Barry R. Davis,
Robert H. Shmerling,
Jordan R. Beach,
Anthony Ishak,
Kenneth J. Mukamal
Publication year - 2020
Publication title -
journal of hypertension
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.249
H-Index - 172
eISSN - 1473-5598
pISSN - 0263-6352
DOI - 10.1097/hjh.0000000000002359
Subject(s) - medicine , atenolol , amlodipine , lisinopril , gout , hazard ratio , chlorthalidone , doxazosin , myocardial infarction , proportional hazards model , uric acid , blood pressure , lower risk , cardiology , confidence interval , angiotensin converting enzyme
Gout is a common complication of blood pressure management and a frequently cited cause of medication nonadherence. Little trial evidence exists to inform antihypertensive selection with regard to gout risk.